New Study Reveals Systemic Effects of Feminizing Hormone Therapy in Transgender Women

Published online January 13, 2026, in Nature Medicine, a groundbreaking study utilizing plasma proteome analysis has shed light on the widespread systemic effects of feminizing gender-affirming hormone therapy (GAHT). This research, available at doi:10.1038/s41591-025-04146-z, promises to improve healthcare for transgender individuals and offers potential insights into sex-specific immune regulation.

Understanding Gender-Affirming Hormone Therapy

Gender-affirming hormone therapy is a crucial component of transgender healthcare, allowing individuals to align their physical characteristics with their gender identity. For transgender women, feminizing hormone therapy typically involves estrogen and anti-androgen medications. While the visible effects of these hormones – such as breast development and changes in body fat distribution – are well-known, the broader, systemic impacts have been less understood. This new study aims to fill that gap.

What is Proteome Analysis?

Proteome analysis is the large-scale study of proteins,notably their structures and functions. Proteins are the workhorses of our cells, carrying out a vast array of tasks. By analyzing the proteins present in a sample – in this case, plasma, the liquid portion of blood – researchers can gain insights into the biological processes occurring within the body. This approach provides a more complete picture than looking at individual hormones alone.

Key Findings of the Study

Researchers analyzed the plasma proteome of transgender women undergoing feminizing hormone therapy, comparing their protein profiles to those of cisgender men and cisgender women. The study revealed meaningful changes in protein levels across multiple biological pathways, indicating that feminizing hormone therapy has far-reaching effects beyond the commonly observed physical changes.

• Immune System Modulation: The study found alterations in proteins related to immune function. This suggests that feminizing hormone therapy can influence the immune system, potentially impacting susceptibility to infections or autoimmune diseases.Further research is needed to fully understand these effects.
• Metabolic Changes: Changes were observed in proteins involved in metabolism, including those related to lipid and glucose regulation. These findings highlight the importance of monitoring metabolic health in transgender women undergoing hormone therapy.
• Cardiovascular Effects: The proteome analysis indicated potential effects on cardiovascular health, with changes in proteins associated with blood clotting and inflammation. This underscores the need for cardiovascular risk assessment and management in this population.
• Liver Function: Proteins related to liver function also showed changes, suggesting that hormone therapy can impact liver health. Regular liver function tests are likely important for individuals on GAHT.

Why This Research Matters

This study represents a significant step forward in understanding the complex effects of feminizing hormone therapy.By identifying specific protein changes, researchers can begin to unravel the underlying mechanisms driving these effects. This knowledge can be used to:

• Personalize hormone Therapy: in the future, proteome analysis could potentially be used to tailor hormone therapy regimens to individual patients, optimizing benefits and minimizing risks.
• Improve Monitoring and Screening: The identified protein markers can serve as targets for monitoring the health of transgender women on hormone therapy, allowing for early detection of potential complications.
• Advance Understanding of Sex-Specific immunity: The observed changes in immune-related proteins could provide valuable insights into the fundamental differences in immune function between sexes, potentially leading to new strategies for preventing and treating diseases.

The Future of Transgender Healthcare

The researchers emphasize that this is just the beginning. More research is needed to confirm these findings in larger and more diverse populations. Longitudinal studies,which follow individuals over time,are particularly important to assess the long-term effects of hormone therapy. Furthermore, similar proteome analyses should be conducted on transgender men undergoing masculinizing hormone therapy to gain a comprehensive understanding of the systemic effects of gender-affirming care.

Key Takeaways

• Feminizing hormone therapy has widespread systemic effects, impacting the immune system, metabolism, cardiovascular health, and liver function.
• Plasma proteome analysis is a powerful tool for understanding these complex effects.
• This research has the potential to improve healthcare for transgender individuals by enabling personalized treatment and better monitoring.
• Further research is needed to confirm these findings and explore the long-term effects of hormone therapy.

This study underscores the importance of comprehensive and individualized healthcare for transgender individuals.By continuing to invest in research, we can ensure that transgender people receive the best possible care and achieve optimal health outcomes.